Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01831284 · ClinicalTrials.gov registry record
Correlates and Consequences of Increased Immune Activation in Injection Drug Users
A clinical trial, sponsored by Rockefeller University.
- Completed
- Registry status
- 201
- Enrollment target
NCT01831284: Completed study, sponsored by Rockefeller University.
NCT01831284 is a clinical trial that has completed, run by Rockefeller University. The registered enrollment target is 201 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01831284 has completed, sponsored by Rockefeller University.
- COMPLETED
- Registry status
- 201 participants
- Enrollment target
Study Summary
The goal of this study is to learn how injection drug use may affect the immune system.
Primary Outcome
Detailed assessments of blood and GI tissue including measurements of HCV viremia in 1) active HIV-1-uninfected IDUs (N=48) 2) a cohort of individuals entering or in drug treatment programs who have stopped injecting for approximately 1 and 3 months (N=48), the majority of whom we anticipate will be infected with HCV; and 3) non-injecting controls (N=48). In addition to obtaining blood and tissue, we will collect behavioral data including injection and other drug use and sexual behaviors.
Interventions
- PROCEDURE Sigmoidoscopy with biopsy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 201 participants |
| Start Date | 2012-12 |
| Est. Completion | 2014-09 |
What the finished NCT01831284 record still lists
NCT01831284 is an observational study that tracks outcomes without assigning an intervention. The registered 201 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Sigmoidoscopy with biopsy is the first listed.
NCT01831284 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01831284 about?
NCT01831284 is a clinical study titled "Correlates and Consequences of Increased Immune Activation in Injection Drug Users". The goal of this study is to learn how injection drug use may affect the immune system.
What is the current status of trial NCT01831284?
This trial is currently completed. The enrollment target is 201 participants. The study started on 2012-12. Estimated completion is 2014-09.
What interventions are being tested in trial NCT01831284?
The interventions under investigation include: Sigmoidoscopy with biopsy (PROCEDURE).
Who is sponsoring clinical trial NCT01831284?
This trial is sponsored by Rockefeller University, which has 117 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04422652 · 201 participants · Phase 2
Combination of Novel Therapies for CKD Comorbid Depression
- NCT05327114 · 201 participants · Phase 2
Efficacy and Safety Study of Nipocalimab for Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
- NCT06099769 · 201 participants · Phase 2
A Study of Enzalutamide, Enzalutamide in Combination With Mifepristone, or Chemotherapy in People With Metastatic Breast Cancer
- NCT06274528 · 201 participants · Phase 2
DORA and LP in Alzheimer's Disease Biomarkers
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia